In summary, we generated a new mAb, AP11, which recognizes CEACAM6, and evaluated its ability to be used as a tool to recognize CEACAM6 expression as a tumor marker in human cancer cells and tissues. The gene discussed is CEACAM6; the disease is neoplasm.